Medicinal chemistry of annonaceous acetogenins: Design, synthesis, and biological evaluation of novel analogues

Molecules

Volumn 14, Issue 9, 2009, Pages 3621-3661

  Kojima, Naoto ^a   Tanaka, Tetsuaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Analogues; Annonaceous acetogenins; Antitumor activity; Polyketides; Structure activity relationship

Indexed keywords

ACETOGENIN; FURAN DERIVATIVE; HYDROCARBON; LACTONE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DESIGN; HUMAN; SYNTHESIS;

ACETOGENINS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; FURANS; HUMANS; HYDROCARBONS; LACTONES;

EID: 70349554503     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14093621     Document Type: Article

References (106)

1. McLaughlin, J.L. Paw paw and cancer: Annonaceous acetogenins from discovery to commercial products. J. Nat. Prod. 2008, 71, 1311-1321.
2. Bermejo, A.; Figadere, B.; Zafra-Polo, M.-C.; Barrachina, I.; Estornell, E.; Cortes, D. Acetogenins from annonaceae. recent progress in isolation, synthesis, and mechanisms of action. Nat. Prod. Rep. 2005, 22, 269-303.
3. Johnson, H.A.; Oberlies, N.H.; Alali, F.Q.; McLaughlin, J.L. Thwarting resistance: Annonaceous acetogenins as new pesticidal and antitumor agents. In Biologically Active Natural Products: Pharmaceuticals; Cutler, S.J., Cutler, H.G., Eds.; CRC Press: Washington, DC, USA, 1999; pp. 173-183.
4. Alali, F.Q.; Liu, X.X.; McLaughlin, J.L. Annonaceous acetogenins: Recent progress. J. Nat. Prod. 1999, 62, 504-540.
5. Zafra-Polo, M.C.; Figadere, B.; Gallardo, T.; Tormo, J.R.; Cortes, D. Natural acetogenins from annonaceae, synthesis and mechanisms of action. Phytochemistry 1998, 48, 1087-1117.
6. Cave, A.; Figadere, B.; Laurens, A.; Cortes, D. Acetogenin from annonaceae. In Progress in the Chemistry of Organic Natural Products; Hertz, W., Kirby, G.W., Moore, R.E., Streglich, W., Tamm, Ch., Eds.; Springer-Verlag: New York, NY, USA, 1997; Vol.70, pp. 81-288.
7. Zeng, L.; Ye, Q.; Oberlies, N.H.; Shi, G.; Gu, Z.-M.; He, K.; McLaughlin, J.L. Recent advances in annonaceous acetogenins. Nat. Prod. Rep. 1996, 13, 275-306. (Pubitemid 26368721)
8. Zafra-Polo, M.C.; Gonzalez, M.C.; Estornell, E.; Sahpaz, S.; Cortes, D. Acetogenins from annonaceae, inhibitors of mitochondrial complex I. Phytochemistry 1996, 42, 253-271.
9. Gu, Z.-M.; Zhao, G.-X.; Oberlies, N.H.; Zeng, L.; McLaughlin, J.L. Annonaceous acetogenins: Potent mitochondrial inhibitors with diverse applications. In Recent Advances in Phytochemistry; Arnason, J.T., Mata, R., Romeo, J.T., Eds.; Plenum Press: New York, NY, USA, 1995; Vol.29, pp. 249-310.
10. Ramirez, E.A.; Hoye, T.R. Determination of relative and absolute configuration in the annonaceous acetogenins. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, The Netherlands, 1995; Volume 17, pp. 251-282.
11. Fang, X.P.; Rieser, M.J.; Gu, Z.M.; Zhao, G.X.; McLaughlin, J.L. Annaceous acetogenins: An updated review. Phytochem. Anal. 1993, 4, 27-67.
12. Rupprecht, J.K.; Hui, Y.-H.; McLaughlin, J.L. Annonaceous acetogenins: A review. J. Nat. Prod. 1990, 53, 237-278.
13. Oberlies, N.H.; Croy, V.L.; Harrison, M.L.; McLaughlin, J.L. The annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. Cancer Lett. 1997, 775, 73-79.
14. Morre, D.J.; de Cabo, R.; Farley, C.; Oberlies, N.H.; McLaughlin, J.L. Mode of action of bullatacin, a potent antitumor acetogenin: Inhibition of NADH oxidase activity of Hela and HL- 60, but not liver, plasma membranes. Life Sci. 1995, 56, 343-348.
15. Li, N.; Shi, Z.; Tang, Y.; Chen, J.; Li, X. Recent progress on the total synthesis of acetogenins from annonaceae. Beilstein J. Org. Chem. 2008, 4, No.48.
16. Hu, T.S.; Wu, Y.L.; Yao, Z.J. Recent progress on the chemical synthesis of annonaceous acetogenins and their structurally modified mimics. In Medicinal Chemistry of Bioactive Natural Products; Liang, X.-T., Fang, W.S., Eds.; John Wiley & Sons, Inc.: West Sussex, UK, 2006; pp. 399-441.
17. Casiraghi, G.; Zanardi, F.; Battistini, L.; Rassu, G. Current advances in the chemical synthesis of annonaceous acetogenins and relatives. Chemtracts 1998, 77, 803-827.
18. Marshall, J.A.; Hinkle, K.W.; Hagedorn, C.E. Recent developments in the synthesis of annonaceous acetogenins. Isr. J. Chem. 1997, 37, 97-107.
19. Figadere, B.; Cave, A. Total stereoselective synthesis of acetogenins of annonaceae: A new class of bioactive polyketides. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, The Netherlands, 1996; Volume 18, pp. 193-227.
20. Hoppe, R.; Scharf, H.D. Annonaceous acetogenins - synthetic approaches towards a novel class of natural products. Synthesis 1995, 1447-1464.
21. Figadere, B. Syntheses of acetogenins of annonaceae: A new class of bioactive polyketides. Acc. Chem. Res. 1995, 28, 359-365.
22. Rodier, S.; Huerou, Y.L.; Renoux B.; Doyon, J.; Renard, P.; Pierre, A.; Gesson, J.-P.; Grée, R. New cytotoxic analogues of annonaceous acetogenins. Anti-Cancer Drug Design 2001, 16, 109-117.
23. Rodier, S.; Huerou, Y.L.; Renoux B.; Doyon, J.; Renard, P.; Pierre, A.; Gesson, J.-P.; Gree, R. Synthesis and cytotoxic activity of acetogenin analogues. Bioorg. Med. Chem. Lett. 2000, 10, 1373-1375.
24. Huerou, Y.L.; Doyon, J.; Gree, R.L. Stereocontrolled synthesis of key advanced intermediates toward simplified acetogenin analogues. J. Org. Chem. 1999, 64, 6782-6790.
25. Sasaki, S.; Maruta, K.; Naito, H.; Sugihara, H.; Hiratani, K.; Maeda, M. New calcium-selective electrodes based on annonaceous acetogenins and their analogs with neighboring bistetrahydrofuran. Tetrahedron Lett. 1995, 36, 5571-5574.
26. Sasaki, S.; Maruta, K.; Naito, H.; Maemura, R.; Kawahara, E.; Maeda, M. Novel acyclic ligands for metal cations based on the adjacent bistetrahydrofuran as analogs of natural annonaceous acetogenins. Tetrahedron 1998, 54, 2401-2410.
27. Peyrat, J.-F.; Mahuteau, J.; Figadère, B.; Cavé, A. NMR studies of Ca2+ complexes of annonaceous acetogenins. J. Org. Chem. 1997, 62, 4811-4815.
28. Yao, Z.J.; Wu, H.-P.; Wu, Y.-L. Polyether mimics of naturally occurring cytotoxic annonaceous acetogenins. J. Med. Chem. 2000, 43, 2484-2487.
29. Zeng, B.-B.; Wu, Y.; Yu, Q.; Wu, Y.-L.; Li, Y.; Chen, X.-G. Enantiopure simple analogues of annonaceous acetogenins with remarkable selective cytotoxicity towards tumor cell lines. Angew. Chem. Int. Ed. 2000, 39, 1934-1937.
30. Zeng, B.-B.; Wu, Y.; Jiang, S.; Yu, Q.; Yao, Z.-J.; Liu, Z.-H.; Li, H.-Y.; Li, Y.; Chen, X.-G.; Wu, Y.-L. Studies on mimicry of naturally occurring annonaceous acetogenins: Non-THF analogues leading to remarkable selective cytotoxicity against human tumor cells, Chem. Eur. J. 2003, 9, 282-290.
31. Jiang, S.; Liu, Z.-H.; Sheng, G.; Zeng, B.-B.; Cheng, X.-G.; Wu, Y.-L.; Yao, Z.-J. Mimicry of annonaceous acetogenins: Enatioselective synthesis of a (4R)-hydroxy analogue having potent antitumor activity. J. Org. Chem. 2002, 67, 3404-3408.
32. Huang, G.-R.; Jiang, S.; Wu, Y.-L.; Jin, Y.; Yao, Z.-J.; Wu, J.-R. Induction of cell death of gastric cancer cells by a modified compound of the annonaceous acetogenin faimily. ChemBioChem 2003, 4, 1216-1221.
33. Jiang, S.; Li, Y.; Chen, X.-G.; Hu, T.-S.; Wu, Y.-L.; Yao, Z.-J. Parallel fragment assembly strategy towards multiple-ether mimicry of anticancer annonaceous acetogenins. Angew. Chem. Int. Ed. 2004, 43, 329-334.
34. Fujita, D.; Ichimaru, N.; Abe, M.; Murai, M.; Hamada, T.; Nishioka, T.; Miyoshi, H. Synthesis of non-THF analogs of acetogenin toward simplified mimics. Tetrahedron Lett. 2005, 46, 5775-5779.
35. Liu, H.-X.; Shao, F.; Li, G.-Q.; Xun, G.-L.; Yao, Z.-J. Tuning the acyclic ether moiety of anticancer agent AA005 with conformationary constrained fragments. Chem. Eur. J. 2008, 74, 8632-8639.
36. Konno, H.; Hiura, N.; Makabe, H.; Abe, M.; Miyoshi, H. Synthesis and mitochondrial complex I inhibition of dihydroxy-cohinbin A, non-THF annonaceous acetogenin analogue. Bioorg. Med. Chem. Lett. 2004, 74, 629-632.
37. Motoyama, T.; Yabunaka, H.; Miyoshi, H. Essential structural factors of acetogenins, potent inhibitors of mitochondrial complex I. Bioorg. Med. Chem. Lett. 2002, 72, 2089-2092.
38. Kuwabara, K.; Takada, M.; Iwata, J.; Tatsumoto, K.; Sakamoto, K.; Iwamura, H.; Miyoshi, H.; Design syntheses and mitochondrial complex I inhibitory activity of novel acetogenin mimics. Eur. J. Biochem. 2000, 267, 2538-2546.
39. Abe, M.; Murai, M.; Ichimaru, N.; Kenmochi, A.; Yoshida, T.; Kubo, A.; Kimura, Y.; Moroda, A.; Makabe, H.; Nishioka, T.; Miyoshi, H. Dynamic function of the alkyl spacer of acetogenins in their inhibitory action with mitochondrial complex I (NADH-ubiquinone oxidoreductase). Biochemistry 2005, 44, 14898-14906.
40. Abe, M.; Kubo, A.; Yamamoto, S.; Hatoh, Y.; Murai, M.; Hattori, Y.; Makabe, H.; Nishioka, T.; Miyoshi, H. Dynamic function of the spacer region of acetogenins in the inhibition of bovine mitochondrial NADH-ubiquinone oxidoreductase (complex I). Biochemistry 2008, 47, 6260-6266.
41. Naito, H.; Kawahara, E.; Maruta, K.; Maeda, M.; Sasaki S.; The first total synthesis of (+)- bullatacin, a potent antitumor annonaceous acetogenin, and (+)-(15,24)-bisepi-bullatacin. J. Org. Chem. 1995, 60, 4419-4427.
42. Shimada, H.; Kozlowski, J.F.; McLaughlin J.L.; The localizations in liposomal membranes of the tetrahydrofuran ring moieties of the annonaceous acetogenins, annonacin and sylvaticin, as detemined by 1H NMR spectoroscopy. Pharmacol. Res. 1998, 37, 357-364.
43. Takeda, M.; Kuwabara, K.; Nakato, H.; Tanaka, A.; Iwamura, H.; Miyoshi, H. Definition of crucial structural factors of acetogenins, potent inhibitors of mitochondrial complex I. Biochim. Biophys. Acta 2000, 7460, 302-310.
44. Miyoshi, H.; Ohshima, M.; Shimada, H.; Akagi, T.; Iwamura, H.; McLaughlin, J.L. Essential structural factors of annonaceous acetogenins as potent inhibitors of mitochondrial complex I. Biochim. Biophys. Acta 1998, 7365, 443-452.
45. Esposti, M.D. Inhibitors of NADH-ubiquinone reductase: An overview. Biochim. Biophys. Acta 1998, 7364, 222-235.
46. Friedrich, T.; Van Heek, P.; Leif, H.; Ohnishi, T.; Forche, E.; Kunze, B.; Jansen, R.; Trowitzsch- Kienast, W.; Höfle, G.; Reichenbach, H.; Weiss, H. Two binding sites of inhibitors in NADH: Ubiquinone oxidoreductase (complex I): Relationship of one site with the ubiquinone-binding site of bacterial glucose: Ubiquinone oxidoreductase. Eur. J. Biochem. 1994, 279, 691-698.
47. Hoppen, S.; Emde, U.; Friedrich, T.; Grubert, L.; Koert, U. Natural-product hybrids: Design, synthesis, and biological evaluation of quinone-annonaceous acetogenins. Angew. Chem. Int. Ed.2000, 39, 2099-2102.
48. Arndt, S.; Emde, U.; Bäurle, S.; Friedrich, T.; Grubert, L. Koert, U. Quinone-annonaceous acetogenins: Synthesis and complex I inhibition studies of a new class of natural product hybrids. Chem. Eur. J. 2001, 7, 993-1005.
49. Yabunaka, H.; Abe, M.; Kenmochi, A.; Hamada, T.; Nishioka, T.; Miyoshi, H. Synthesis and inhibitory activity of ubiquinone-acetogenin hybrid inhibitor with bovine mitochondrial complex I. Bioorg. Med. Chem. Lett. 2003, 13, 2385-2388.
50. Ohshima, M.; Miyoshi, H.; Sakamoto, K.; Takegami, K.; Iwata, J.; Kuwabara, K.; Iwamura, H. Yagi, T. Characterization of the ubiquinone reduction site of mitochondrial complex I using bulky synthetic ubiquinones. Biochemistry 1998, 37, 6436-6445.
51. Ichimaru, N.; Abe, M.; Kenmochi, A.; Hamada, T.; Nishioka. T.; Miyoshi, H. Synthesis of 13C- labeled ubiquinone-acetogenin hybrid inhibitors of mitochondrial complex I. J. Pestic. Sci. 2004, 29, 127-129.
52. Derbre, S.; Duval, R.; Roue, G.; Garofano, A.; Poupon, E.; Brandt, U.; Susin, S. A.; Hocquemiller, R. Semisynthesis and screening of a small library of pro-apoptotic squamocin analogues: Selection and study of a benzoquinone hybrid with an improved biological profile. ChemMedChem 2006, 1, 118-129.
53. Gallardo, T.; Zafra-Polo, M.C.; Tormo, J.R.; Gonzalez, M.C.; Franck, X.; Estornell, E.; Cortes D. Semisynthesis of antitumoral acetogenins: SAR of functionalized alkyl-chain bis- tetrahydrofuranic acetogenins, specific inhibitors of mitochondrial complex I. J. Med. Chem. 2000, 43, 4793-4800.
54. Tormo, J.R.; Estornell, E.; Gallardo, T.; Gonzalez, M.C.; Cave, A.; Granell, S.; Cortes, D.; Zafra- Polo, M.C.; y-Lactone-functionalized antitumoral acetogenins are the most potent inhibitors of mitochondrial complex I. Bioorg. Med. Chem. Lett. 2001, 11, 681-684.
55. Tormo, J.R.; Gallardo, T.; Peris, E.; Bermejo, A.; Cabedo, N.; Estornell, E.; Zafra-Polo, M.C.; Cortes, D. Inhibitory effects on mitochondrial complex I of semisynthetic mono-tetrahydrofuran acetogenin derivatives. Bioorg. Med. Chem. Lett. 2003, 13, 4101-4105.
56. Tormo, J.R.; Royo, I.; Gallardo, T.; Zafra-Polo, M.C.; Hernandez, P.; Cortes, D.; Pelaez, F. In vitro antitumor structure-activity relationships of threo/trans/threo mono-tetrahydrofuranic acetogenins: Correlations with their inhibition of mitochondrial complex I. Oncol. Res. 2003, 14, 147-154.
57. Duret, P.; Figadere, B.; Hocquemiller, R.; Cave, A. Epimerization of annonaceons acetogenins under basic conditions. Tetrahedron Lett. 1997, 38, 8849-8852.
58. Hoye, T.R.; Hanson, P.R. Assigning the relative stereochemistry between C(2) and C(4) of the 2- acetonyl-4-alkylbutyrolactone substructures of the appropriate annonaceous acetogenins. J. Org. Chem. 1991, 56, 5092-5095.
59. Duval, R.A.; Poupon, E.; Brandt, U.; Hocquemiller, R. Remarkable substituent effect: Β- Aminosquamocin, a potent dual inhibitor of mitochondrial complex I and III. Biochim. Biophys. Acta 2005, 1709, 191-194.
60. Duval, R.A.; Lewin, G.; Hocquemiller, R. Semisynthesis of heterocyclic analogues of squamocin, a cytotoxic annonaceous acetogenin, by unusual oxadative decarboxylation reaction. Bioorg. Med. Chem. 2003, 11, 3439-3446.
61. Duval, R.; Lewin, G.; Peris, E.; Chahboune, N.; Garofano, A.; Drose, S.; Cortes, D.; Brandt, U.; Hocquemiller, R. Heterocyclic analogues of squamocin as inhibitors of mitochondrial complex I. one the role of the terminal lactone of annonaceous acetogenins. Biochemistry 2006, 45, 2721-2728.
62. Duval, R.A.; Poupon, E.; Romero, V.; Peris, E.; Lewin, G.; Cortes, D.; Brandt, U.; Hocquemiller, R. Analogues of cytotoxic squamocin using reliable reactions: New insights into the reactivity and role of the α,Β- unsaturated lactone of the annonaceous acetogenins. Tetrahedron 2006, 62, 6248-6257.
63. Kojima, N.; Fushimi, T, Maezaki, N.; Tanaka, T.; Yamori, T. Synthesis of hydrid acetogenins, αΒ-unsaturated-γ-lactone-free nitrogen-containing heterocyclic analogues, and their cytotoxicity against human cancer cell lines. Bioorg. Med. Chem. Lett. 2008, 78, 1637-1641.
64. Frantz, D.E.; Fässler, R.; Carreira, E.M. Facile enantioselective synthesis of propargylic alcohols by direct addition of terminal alkynes to aldehydes. J. Am. Chem. Soc. 2000, 722, 1806-1807.
65. Yamori, T.; Matsunaga, A.; Sato, S.; Yamazaki, K.; Komi, A.; Ishizu, K. Mita, I.; Edatsugi, H.; Matsuba, Y.; Takezawa, K.; Nakanishi, O.; Kohno, H.; Nakajima, Y.; Komatsu, H.; Andoh, T.; Tsuruo T. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res. 1999, 59, 4042-4049.
66. Liu, H.-X.; Huang, G.-R.; Zhang, H.-M.; Wu, J.-R.; Yao, Z.-J. Annonaceous acetogenin mimics bearing a terminal lactam and their cytotoxicity against cancer cells. Bioorg. Med. Chem. Lett. 2007, 77, 3426-3430.
67. Schultz, W.J.; Etter, M.C.; Pocius, A.V.; Smith, S. A new family of cation-binding compounds: Threo-αω,co-poly(cyclooxalkane)diyl. J. Am. Chem. Soc. 1980, 702, 7981-7982.
68. Sasaki, S.; Naito, H.; Maruta, K.; Kawahara, E.; Maeda, M. Novel calcium ionophores: Supramolecular complexation by the hydroxylated-bistetrahydrofuran skeleton of potent antitumor annonaceous acetogenins. Tetrahedron Lett. 1994, 35, 3337-3340.
69. Sasaki, S.; Maruta, K.; Naito, H.; Maemura, R.; Kawahara, E.; Maeda M. In vitro antitumor activities of new synthetic bistetrahydrofuran derivatives as analogs of annonaceous acetogenins. Chem. Pharm. Bull. 1998, 46, 154-158.
70. Shimada, H.; Grutzner, J.B.; Kozlowski, J.F.; McLaughlin, J.L. Membrane conformations and their relation to cytotoxicity of asimicin and its analogues. Biochemistry 1998, 37, 854-866.
71. Born, L.; Lieb, F.; Lorentzen, J.P.; Moeschler, H.; Nonfon, M.; Söllner, R.; Wendisch, D. The relative configuration of acetogenins isolated from annona squamosa: Annonin I (squamocin) and annonin VI. Planta Med. 1990, 56, 312-316.
72. Sasaki, S.; Shibata, T.; Torigoe, H.; Shibata, Y.; Maeda M. Novel class of DNA binding motifs based on bistetrahydrofuran and bisfuran skeleton with long alkyl chains. Nucleos. Nucleot. Nucleic Acids 2001, 20, 551-558.
73. Hamada, T.; Ichimaru, N.; Abe, M.; Fujita, D.; Kenmochi, A.; Nishioka, T.; Zwicker, K.; Brandt, U.; Miyoshi, H. Synthesis and inhibitory action of novel acetogenin mimics with bovine heart mitochondorial complex I. Biochemistry 2004, 43, 3651-3658. (Pubitemid 38391719)
74. Ichimaru, N.; Murai, M.; Abe, M.; Hamada, T.; Yamada, Y.; Makino, S.; Nishioka, T.; Makabe, H.; Makino, A.; Kobayashi, T.; Miyoshi, H. Synthesis and inhibition mechanism of δlac- acetogenins, a novel type of inhibitor of bovine heart mitochondrial complex I. Biochemistry 2005, 44, 816-825.
75. Ichimaru, N.; Abe, M.; Murai, M.; Senoh, M.; Nishioka, T.; Miyoshi, H. Function of the alkyl side chains of δlac-acetogenins in the inhibitory effect on mitochondrial complex I (NADH- ubiquinone oxidoreductase). Bioorg. Med. Chem. Lett. 2006, 16, 3555-3558.
76. Murai, M.; Ichimaru, N.; Abe, M.; Nishioka, T.; Miyoshi, H. Mode of inhibitory action of Alac- acetogenins, a new class of inhibitors of bovine heart mitochondrial complex I. Biochemistry 2006, 45, 9778-9787.
77. Murai, M.; Ichimaru, N.; Abe, M.; Nishioka, T.; Miyoshi, H. Synthesis of photolabile δlac- acetogenin for photoaffinity labeling of mitochondrial complex I. J. Pestic. Sci. 2006, 31, 156-158.
78. Ichimaru, N.; Yoshinaga, N.; Nishioka, T.; Miyoshi, H. Effect of stereochemistry of δlac- acetogenins on the inhibition of mitochondrial complex I (NADH-ubiquinone oxidoreductase). Tetrahedron 2007, 63, 1127-1139.
79. Miyoshi, H.; Ichimaru, N.; Murai, M. Synthesis and inhibitory action of novel acetogenin mimics Alac-acetogenins: A new class of inhibitors of mitochondrial NADH-ubiquinone oxidoreductase (complex-I). In Pesticide Chemistry: Crop Protection, Public Health, Environmental Safety; Ohkawa, H., Miyagawa, H., Lee, P.W., Eds.; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2007; pp. 171-174.
80. Ichimaru, N.; Murai, M.; Kakutani, N.; Kako, J.; Ishihara, A.; Nakagawa, Y.; Nishioka, T.; Yagi, T.; Miyoshi, H. Biochemistry 2008, 47, 10816-10826.
81. Ye, Q.; Shi, G.; He, K.; McLaughlin, J.L. Chlorinated annonaceous acetogenins and their bioactivities. J. Nat. Prod. 1996, 59, 994-996.
82. Kojima, N.; Hayashi, H.; Suzuki, S.; Tominaga, H.; Maezaki, N.; Tanaka, T.; Yamori, T. Syntheisis of C4-fluorinated solamins and their growth inhibitroy activity against human cancer cell lines. Bioorg. Med. Chem. Lett. 2008, 18, 6451-6453.
83. Beeson, T.D.; MacMillan, D.W.C. Enantioselective organocatalytic α-fluorination of aldehydes. J. Am. Chem. Soc. 2005, 127, 8826-8828.
84. Maezaki, N.; Kojima, N.; Tanaka T.; Systematic synthesis of diastereomeric THF ring cores and total synthesis of anti-tumor annonaceous acetogenins. Synlett 2006, 993-1003.
85. Tominaga, H.; Maezaki, N.; Yanai, M.; Kojima, N.; Urabe, D.; Ueki, R.; Tanaka, T. First total synthesis of longimicin D. Eur. J. Org. Chem. 2006, 1422-1429.
86. Maezaki, N.; Tominaga, H.; Kojima, N.; Yanai, M.; Urabe, D.; Ueki, R.; Tanaka, T.; Yamori, T. Total synthesis of murisolins and evaluation of tumor-growth inhibitory activity. Chem. Eur. J. 2005, 11, 6237-6245.
87. Maezaki, N.; Tominaga, H.; Kojima, N.; Yanai, M.; Urabe, D.; Tanaka, T. First total synthesis of murisolin. Chem. Commun. 2004, 406-407.
88. Kojima, N. Systematic synthesis of antitumor annonaceous acetogenins. Yakugaku Zasshi 2004, 124, 673-681.
89. Kojima, N.; Maezaki, N.; Tominaga, H.; Yanai, M.; Urabe, D.; Tanaka, T. Stereodivergent and reiterative synthesis of bistetrahydrofuran ring cores of annonaceous acetogenins. Chem. Eur. J. 2004, 10, 672-680.
90. Kojima, N.; Maezaki, N.; Tominaga, H.; Asai, M.; Yanai, M.; Tanaka, T. Systematic construction of a monotetrahydrofuran-ring library in annonaceous acetogenins by asymmetric alkynylation and stereodivergent tetrahydrofuran-ring formation. Chem. Eur. J. 2003, 9, 4980-4990.
91. Maezaki, N.; Kojima, N.; Tominaga, H.; Yanai, M.; Tanaka, T. Systematic synthesis of bis-THF ring cores in annonaceous acetogenins. Org. Lett. 2003, 5, 1411-1414.
92. Maezaki, N.; Kojima, N.; Asai, M.; Tominaga, H.; Tanaka, T. Highly stereoselective and stereodivergent synthesis of four types of THF cores in acetogenins using a C4-chiral building block. Org. Lett. 2002, 4, 2977-2980.
93. Gallardo, T.; Saez, J.; Granados, H.; Tormo, J.R.; Velez, I.D.; Brun, N.; Torres, B.; Cortes, D. 10-Oximeguanacone, the first nitrogenated acetogenin derivative found to be a potent inhibitor of mitochondrial complex I. J. Nat. Prod. 1998, 67, 1001-1005.
94. Tormo, J.R.; DePedro, N.; Royo, I.; Barrachina, I.; Zafra-Polo, M.C; Cuadrillero, C.; Hernández, P.; Cortes, D.; Peláez, F. In vitro antitumor structure-activity relationships of threo/trans/threo/trans/erythro bis-tetrahydrofuranic acetogenins: Correlations with their inhibition of mitochondrial complex I. Oncol. Res. 2005, 75, 129-138.
95. Royo, I.; DePedro, N.; Estornell, E.; Cortes, D.; Peláez, F.; Tormo, J.R. In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: Correlations with their inhibition of mitochondrial complex I. Oncol. Res. 2003, 73, 521-528.
96. Duret, P.; Hocquemiller, R.; Gantier, J.-C.; Figadere, B. Semisynthesis and cytotoxicity of amino acetogenins and derivatives. Bioorg. Med. Chem. 1999, 7, 1821-1826.
97. Duval, R.A.; Duret, P.; Lewin, G.; Peris, E.; Hocquemiller, R. Semisynthesis and biological activity of aminoacyl triesters of squamocin, an annonaceous acetogenin. Bioorg. Med. Chem. 2005, 73, 3773-3781.
98. Queiroz, E.F.; Roblot, F.; Duret, P.; Figadère, B.; Gouyette, A.; Laprévote, O.; Serani, L.; Hocquemiller, R. Synthesis, spectroscopy, and cytotoxicity of glycosylated acetogenin derivatives as promising molecules for cancer therapy. J. Med. Chem. 2000, 43, 1604-1610.
99. Han, H.; Sinha, M.K.; D'Souza, L.J.; Keinan, E.; Sinha, S.C. Total synthesis of 34- hydroxyasimicin and its photoactive derivative for affinity labeling of the mitochondrial complex I. Chem. Eur. J. 2004, 70, 2149-2158.
100. Derbre, S.; Roué, G.; Poupon, E.; Susin, S.A.; Hocquemiller, R. Annonaceous acetogenins: The hydroxyl groups and THF rings are crucial structural elementals for targeting the mitochondria, demonstration with the synthesis of fluorescent squamocin analogues. Chem Bio Chem 2005, 6, 979-982.
101. Derbré, S.; Gil, S.; Taverna, M.; Boursier, C.; Nicolas, V.; Demey-Thomas, E.; Vinh, J.; Susin, S.A.; Hocquemiller, R.; Poupon, E. Highly cytotoxic and neurotoxic acetogenins of the annonaceae: New putative biological targets of squamocin detected by activity-based protein profiling. Bioorg. Med. Chem. Lett. 2008, 78, 5741-5744.
102. Fujita, D.; Murai, M.; Nishioka, T.; Miyoshi, H. Light control of mitochondrial complex I activity by a photoresponsive inhibitor. Biochemistry 2006, 45, 6581-6586.
103. Murai, M.; Ishihara, A.; Nishioka, T.; Yagi, T.; Miyoshi, H. The ND1 subunit constructs the inhibitor binding domain in bovine heart mitochondrial complex I. Biochemistry 2007, 46, 6409-6416.
104. Liu, H.-X.; Huang, G.-R.; Zhang, H.-M.; Jiang, S.; Wu, J.-R.; Yao, Z.-J. A structure-activity guided strategy for fluorescent labeling of annonaceous acetogenin mimetics and their application in cell biology. Chem Bio Chem 2007, 8, 172-177.
105. Maezaki, N.; Urabe, D.; Yano, M.; Tominaga, H.; Morioka, T.; Kojima, N.; Tanaka, T. Synthesis of fluorescent solamin for visualization of cell distribution. Heterocycles 2007, 73, 159-164.
106. Kojima, N.; Morioka, T.; Yano, M.; Suga, Y. Maezaki, N.; Tanaka, T. Convergent synthesis of fluorescence labelled solamin. Heterocycles 2009, 79, 387-393.